Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
gptkb:SPT-624
gptkb:SPT624 |
| gptkbp:CASNumber |
1808287-01-5
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Spero_Therapeutics
|
| gptkbp:hasDevelopmentCode |
gptkb:SPT_624
|
| https://www.w3.org/2000/01/rdf-schema#label |
SPT 624
|
| gptkbp:indication |
urinary tract infection
complicated urinary tract infection multidrug-resistant Gram-negative bacterial infections |
| gptkbp:isAntibiotic |
true
|
| gptkbp:isInClinicalTrials |
true
|
| gptkbp:isOralDrug |
true
|
| gptkbp:mechanismOfAction |
beta-lactamase inhibitor
|
| gptkbp:target |
Gram-negative bacteria
|
| gptkbp:bfsParent |
gptkb:Strathaven
|
| gptkbp:bfsLayer |
7
|